Fatty Liver News and Research

Latest Fatty Liver News and Research

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.

29 Apr 2022

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery.

From CN Bio Innovations Ltd 26 Apr 2022

Researchers uncover a new protective mechanism against non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD), commonly known as fatty liver disease, is a prevalent disease frequently seen in obese people. Having high fat content in the liver is detrimental as it is strongly associated with severe health problems like diabetes, high blood pressure, and liver cancer.

20 Apr 2022

About one in four adults has a liver condition that is a risk factor for heart disease

It is estimated that about one in four adults worldwide has a liver condition that is a risk factor for heart disease, according to a new American Heart Association scientific statement published today in the Association's peer-reviewed journal Arteriosclerosis, Thrombosis, and Vascular Biology.

14 Apr 2022

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.

7 Apr 2022

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease.

3 Apr 2022

Exploring the vital connection between gut microbes, physical activity, and health

Our bowels accommodate billions of active microbes that affect the health, a fact that is arousing increasing interest also among athletes.

26 Mar 2022

Study: Liver disease negatively impacted by lifestyle changes during the pandemic

Liver disease negatively impacted by lifestyle changes during the first year of the pandemic, according to a new study in the journal Liver International.

25 Mar 2022

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive prognostic tool.

From Siemens Healthineers Laboratory Diagnostics 17 Mar 2022

Targeting regulation of subcellular architecture may hold opportunities to treat metabolic diseases

Cells use their molecular architecture to regulate their metabolic functions, and repairing diseased cells' architecture to a healthier state can also repair metabolism, according to a study led by Harvard T.H. Chan School of Public Health researchers.

10 Mar 2022

High-fat diet combined with liquid fructose intake accelerates fat accumulation in the liver

A high-fat diet is not enough to cause short-term fatty liver disease. However, if this diet is combined with the intake of beverages sweetened with liquid fructose, the accumulation of fats in the liver accelerates and hypertriglyceridemia —a cardiovascular risk factor— can appear.

4 Mar 2022

Long or irregular menstrual cycles may be linked with increased risk of NAFLD

Women with long or irregular periods are known to have a higher risk of type 2 diabetes and heart disease, but researchers found these women may also be at risk for nonalcoholic fatty liver disease (NAFLD), according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

3 Mar 2022

COVID-19 severity is correlated with body composition

In a recent study posted to the medRxiv* preprint server, researchers assessed the effect of changes in the abdominal well-being and physique on coronavirus disease 2019 (COVID-19) severity using magnetic resonance imaging (MRI).

28 Feb 2022

Exercise may help reduce the risk of blood clots in patients with aggressive form of NAFLD

Exercise may help certain patients with nonalcoholic fatty liver disease (NAFLD) reduce their risk of developing blood clots, according to a new study by Penn State College of Medicine researchers.

28 Feb 2022

Livers of men with hepatic diseases undergo sex-change

The livers of men diagnosed with hepatic diseases change sex as part of a potential self-protective mechanism, according to University of Queensland research.

21 Feb 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

Gut microbial signatures associated with increased risk of developing type 2 diabetes

A new study identified microbial signatures which predicted the onset of type 2 diabetes during nearly 16 years of follow-up in a large Finnish population cohort.

16 Feb 2022

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift from Richard Todd Stravitz, M.D., and his family's Barbara Brunckhorst Foundation.

15 Feb 2022

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

A study in mice - led by researchers at Washington University School of Medicine in St. Louis - shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome.

12 Feb 2022

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

In Germany, liver cirrhosis has the highest mortality rate of any chronic disease requiring hospital admission. When diagnosed as a comorbidity of other chronic diseases, liver cirrhosis at least doubles the mortality rate.

12 Feb 2022

Fatty Liver News and Research

Latest Fatty Liver News and Research

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

Researchers uncover a new protective mechanism against non-alcoholic fatty liver disease

About one in four adults has a liver condition that is a risk factor for heart disease

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

Multi-mineral supplement could help reduce downstream consequences of fatty liver disease

Exploring the vital connection between gut microbes, physical activity, and health

Study: Liver disease negatively impacted by lifestyle changes during the pandemic

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

Targeting regulation of subcellular architecture may hold opportunities to treat metabolic diseases

High-fat diet combined with liquid fructose intake accelerates fat accumulation in the liver

Long or irregular menstrual cycles may be linked with increased risk of NAFLD

COVID-19 severity is correlated with body composition

Exercise may help reduce the risk of blood clots in patients with aggressive form of NAFLD

Livers of men with hepatic diseases undergo sex-change

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Gut microbial signatures associated with increased risk of developing type 2 diabetes

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Fatty Liver News and Research

Latest Fatty Liver News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in